SAKAR

Sakar Healthcare Share Price

 

 

Start SIP in SAKAR

Start SIP

Performance

  • Low
  • ₹404
  • High
  • ₹410
  • 52 Week Low
  • ₹210
  • 52 Week High
  • ₹444
  • Open Price₹404
  • Previous Close₹407
  • Volume8,408

Investment Returns

  • Over 1 Month + 4.81%
  • Over 3 Month + 10.84%
  • Over 6 Month + 15.61%
  • Over 1 Year + 34.8%

Smart Investing Starts Here Start SIP with Sakar Healthcare for Steady Growth!

Invest Now

Sakar Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 46.4
  • PEG Ratio
  • 0.8
  • Market Cap Cr
  • 905
  • P/B Ratio
  • 3
  • Average True Range
  • 14.31
  • EPS
  • 8.79
  • Dividend Yield
  • 0
  • MACD Signal
  • 8.97
  • RSI
  • 51
  • MFI
  • 33.71

Sakar Healthcare Financials

Sakar Healthcare Technicals

EMA & SMA

Current Price
₹406.55
-0.35 (-0.09%)
pointer
  • Bearish Moving Average 7
  • Bullish Moving Average 9
  • 20 Day
  • ₹408.68
  • 50 Day
  • ₹393.78
  • 100 Day
  • ₹375.12
  • 200 Day
  • ₹352.71

Resistance and Support

406.73 Pivot Speed
  • R3 415.27
  • R2 412.48
  • R1 409.52
  • S1 403.77
  • S2 400.98
  • S3 398.02

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Sakar Healthcare has an operating revenue of Rs. 203.96 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 12% is healthy, ROE of 6% is fair but needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 21% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 8% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 55 which is a POOR score indicating inconsistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Ethical Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Sakar Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-07 Quarterly Results & Others To consider other business matters.
2025-07-25 Quarterly Results & Others To consider other business matters.
2025-05-15 Audited results
2025-02-08 Quarterly Results
2024-10-22 Quarterly Results

Sakar Healthcare F&O

Sakar Healthcare Shareholding Pattern

52.86%
13.31%
16.02%
17.81%

About Sakar Healthcare

  • NSE Symbol
  • SAKAR
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Sanjay S Shah
  • ISIN
  • INE732S01012

Similar Stocks to Sakar Healthcare

Sakar Healthcare FAQs

Sakar Healthcare share price is ₹406 As on 02 January, 2026 | 18:53

The Market Cap of Sakar Healthcare is ₹904.6 Cr As on 02 January, 2026 | 18:53

The P/E ratio of Sakar Healthcare is 46.4 As on 02 January, 2026 | 18:53

The PB ratio of Sakar Healthcare is 3 As on 02 January, 2026 | 18:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23